291 related articles for article (PubMed ID: 24239860)
1. Modeling vitamin D actions in triple negative/basal-like breast cancer.
LaPorta E; Welsh J
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():65-73. PubMed ID: 24239860
[TBL] [Abstract][Full Text] [Related]
2. Characterization of mammary tumor cell lines from wild type and vitamin D3 receptor knockout mice.
Zinser GM; McEleney K; Welsh J
Mol Cell Endocrinol; 2003 Feb; 200(1-2):67-80. PubMed ID: 12644300
[TBL] [Abstract][Full Text] [Related]
3. Comparative regulation of gene expression by 1,25-dihydroxyvitamin D3 in cells derived from normal mammary tissue and breast cancer.
Beaudin SG; Robilotto S; Welsh J
J Steroid Biochem Mol Biol; 2015 Apr; 148():96-102. PubMed ID: 25239595
[TBL] [Abstract][Full Text] [Related]
4. IL-6 Impairs the Activity of Vitamin D3 in the Regulation of Epithelial-Mesenchymal Transition in Triple Negative Breast Cancer.
Abdel-Mohsen MA; Abo Deif SM; Abou-Shamaa LA
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2267-2273. PubMed ID: 31450894
[TBL] [Abstract][Full Text] [Related]
5. Stable expression of human VDR in murine VDR-null cells recapitulates vitamin D mediated anti-cancer signaling.
Keith ME; LaPorta E; Welsh J
Mol Carcinog; 2014 Apr; 53(4):286-99. PubMed ID: 23681781
[TBL] [Abstract][Full Text] [Related]
6. Anti-proliferative action of vitamin D in MCF7 is still active after siRNA-VDR knock-down.
Costa JL; Eijk PP; van de Wiel MA; ten Berge D; Schmitt F; Narvaez CJ; Welsh J; Ylstra B
BMC Genomics; 2009 Oct; 10():499. PubMed ID: 19863778
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer cell regulation by high-dose Vitamin D compounds in the absence of nuclear vitamin D receptor.
Valrance ME; Welsh J
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):221-5. PubMed ID: 15225775
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of hybrid vitamin D receptor agonist/histone deacetylase inhibitors in vitamin D-resistant triple-negative 4T1 breast cancer.
Bijian K; Kaldre D; Wang TT; Su J; Bouttier M; Boucher A; Alaoui-Jamali M; White JH; Gleason JL
J Steroid Biochem Mol Biol; 2018 Mar; 177():135-139. PubMed ID: 28847749
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D regulation of HAS2, hyaluronan synthesis and metabolism in triple negative breast cancer cells.
Narvaez CJ; Grebenc D; Balinth S; Welsh JE
J Steroid Biochem Mol Biol; 2020 Jul; 201():105688. PubMed ID: 32360595
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer.
Thakkar A; Wang B; Picon-Ruiz M; Buchwald P; Ince TA
Breast Cancer Res Treat; 2016 May; 157(1):77-90. PubMed ID: 27120467
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of vitamin D receptor in mammospheres: implications for vitamin D resistance in breast cancer and potential for combination therapy.
Pervin S; Hewison M; Braga M; Tran L; Chun R; Karam A; Chaudhuri G; Norris K; Singh R
PLoS One; 2013; 8(1):e53287. PubMed ID: 23341935
[TBL] [Abstract][Full Text] [Related]
12. A sorafenib-sparing effect in the treatment of thyroid carcinoma cells attained by co-treatment with a novel isoflavone derivative and 1,25 dihydroxyvitamin D3.
Izkhakov E; Sharon O; Knoll E; Aizic A; Fliss DM; Kohen F; Stern N; Somjen D
J Steroid Biochem Mol Biol; 2018 Sep; 182():81-86. PubMed ID: 29702263
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D compounds inhibit cancer stem-like cells and induce differentiation in triple negative breast cancer.
Shan NL; Wahler J; Lee HJ; Bak MJ; Gupta SD; Maehr H; Suh N
J Steroid Biochem Mol Biol; 2017 Oct; 173():122-129. PubMed ID: 27923595
[TBL] [Abstract][Full Text] [Related]
14. Gene Signatures of 1,25-Dihydroxyvitamin D3 Exposure in Normal and Transformed Mammary Cells.
Simmons KM; Beaudin SG; Narvaez CJ; Welsh J
J Cell Biochem; 2015 Aug; 116(8):1693-711. PubMed ID: 25736056
[TBL] [Abstract][Full Text] [Related]
15. Transcriptomic Response to 1,25-Dihydroxyvitamin D in Human Fibroblasts with or without a Functional Vitamin D Receptor (VDR): Novel Target Genes and Insights into VDR Basal Transcriptional Activity.
Costa PLF; França MM; Katayama ML; Carneiro ET; Martin RM; Folgueira MAK; Latronico AC; Ferraz-de-Souza B
Cells; 2019 Apr; 8(4):. PubMed ID: 30959822
[TBL] [Abstract][Full Text] [Related]
16. Mammary adipocytes bioactivate 25-hydroxyvitamin D₃ and signal via vitamin D₃ receptor, modulating mammary epithelial cell growth.
Ching S; Kashinkunti S; Niehaus MD; Zinser GM
J Cell Biochem; 2011 Nov; 112(11):3393-405. PubMed ID: 21769914
[TBL] [Abstract][Full Text] [Related]
17. Dissociation of growth arrest and CYP24 induction by VDR ligands in mammary tumor cells.
Valrance ME; Brunet AH; Acosta A; Welsh J
J Cell Biochem; 2007 Aug; 101(6):1505-19. PubMed ID: 17286279
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of bifunctional vitamin D receptor agonist-histone deacetylase inhibitor hybrid molecules in triple-negative breast cancer.
Barbier C; Mansour A; Ismailova A; Sarmadi F; Scarlata DA; Bouttier M; Zeitouni C; Wang C; Gleason JL; White JH
Sci Rep; 2022 Apr; 12(1):6745. PubMed ID: 35468986
[TBL] [Abstract][Full Text] [Related]
19. VDR in salivary gland homeostasis and cancer.
DeSantis KA; Robilotto SL; Matson M; Kotb NM; Lapierre CM; Minhas Z; Leder AA; Abdul K; Facteau EM; Welsh J
J Steroid Biochem Mol Biol; 2020 May; 199():105600. PubMed ID: 31958633
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D analogues exhibit antineoplastic activity in breast cancer patient-derived xenograft cells.
Ferronato MJ; Nadal Serrano M; Arenas Lahuerta EJ; Bernadó Morales C; Paolillo G; Martinez-Sabadell Aliguer A; Santalla H; Mascaró M; Vitale C; Fall Y; Arribas J; Facchinetti MM; Curino AC
J Steroid Biochem Mol Biol; 2021 Apr; 208():105735. PubMed ID: 32784045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
